about
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of mon...
Read More
2.01
0.02
(1.01%)
25,619
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Adagene Inc - ADR is on 08 Aug 2025 for the purpose of Adagene Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Adagene Inc - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..